SEC Filing S-1: Clearside Biomedical, Inc.
January 8, 2016 3:15pm EST
Source: SEC (Index ) via Sqoop
Form S-1
Exhibits
3.1
Fifth Amended and Restated Certificate of Incorporation, as currently in effect.
3.4
Bylaws, as currently in effect.
4.2
Third Amended and Restated Investor Rights Agreement, dated as of November 23, 2015, by and among the Registrant and certain of its stockholders.
4.3
Form of Common Stock Purchase Warrant issued in bridge financing.
4.4
Stock Warrant issued to North Carolina Biotechnology Center, dated as of February 12, 2013.
4.5
Warrant to Purchase Stock issued to Silicon Valley Bank, dated as of April 15, 2015.
10.1
License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated as of July 4, 2012, as amended by the First Amendment to License Agreement, dated April 2, 2014.
10.2
Lease Agreement, dated as of March 14, 2012, by and between the Registrant and McDonald Ventures XI, LLC, as amended by the renewal letter from McDonald Ventures XI, LLC to the Registrant, dated March 18, 2014, and by the First Amendment to the Lease Agreement, dated August 22, 2014.
10.3
2011 Stock Incentive Plan, as amended to date.
10.4
Form of Incentive Stock Option Grant Notice and Incentive Stock Option Agreement under 2011 Stock Incentive Plan.
10.5
Form of Nonqualified Stock Option Grant Notice and Nonqualified Stock Option Agreement under 2011 Stock Incentive Plan.
10.9
Form of Indemnification Agreement with non-employee directors.
10.10
Collaboration Agreement, dated as of January 31, 2013, by and among the Registrant and Santen Pharmaceutical Co., Ltd., as amended by Amendment No. 1 to Collaboration Agreement, dated as of April 29, 2014.
10.11
Amendment No. 2 to Collaboration Agreement, dated as of April 30, 2015, by and among the Registrant and Santen Pharmaceutical Co., Ltd.
10.13
Executive Employment Agreement, by and between the Registrant and Daniel H. White, dated as of January 1, 2015.
10.14
Executive Employment Agreement, by and between the Registrant and Charles Deignan, dated as of January 1, 2015.
10.15
Executive Employment Agreement, by and between the Registrant and Glenn Noronha, dated as of January 1, 2015.
10.17
License Agreement, by and between the Registrant and NovaMedica LLC, dated as of August 29, 2014.
10.18
Research, Option and License Agreement, by and between the Registrant and Spark Therapeutics, Inc., dated as of April 27, 2015.
10.19
Loan and Security Agreement, by and between and Registrant and Silicon Valley Bank, dated as of April 15, 2015.
23.1
Consent of Ernst & Young LLP, independent registered public accounting firm.